Skip to main content
. Author manuscript; available in PMC: 2022 Oct 25.
Published in final edited form as: J Thorac Cardiovasc Surg. 2020 Dec 13;163(4):e313–e328. doi: 10.1016/j.jtcvs.2020.11.160

FIGURE 8.

FIGURE 8.

Intrapleural IL-2 expressing oncolytic virotherapy mediates superior antitumor efficacy and enhances T-cell receptor diversity in an MPD model. Local administration of an IL-2 expressing VV reduces tumor burden, which is associated with increased CD4+ and CD8+ T-cell infiltrate and αβ T-cell receptor diversity in an MPD model.